
CTT PHARMACEUTICAL HOLDINGS, INC.
OTC · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
CTT Pharmaceutical Holdings, Inc. develops and manufactures pharmaceutical products, including generic and specialty formulations, for distribution to healthcare and consumer markets.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Buy | $204 | 3,700at $0.06 | Oct 6, 2026 |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Buy | $518 | 11,500at $0.04 | Aug 20, 2026 |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Buy | $116 | 2,100at $0.06 | Aug 24, 2026 |
| CTT PHARMACEUTICAL HOLDINGS, INC.CEO | Buy | $590 | 10,000at $0.06 | Aug 19, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CTTH activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.